BCDA vs GPC · $14.4M cap vs P/E 21, rev $23.49B
Biocardia Inc (BCDA) versus Genuine Parts Co (GPC) — a side-by-side from cached financials, not a winner call.
Biocardia Inc (BCDA) is a biotechnology company listed on NASDAQ.
Genuine Parts Co (GPC) is a auto parts company listed on US.
BCDA does not have a complete income-statement cache yet.
Latest reported GPC revenue for 2024-12-31 was $23.49B. Net income was $904.1M. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
BCDA currently screens at market cap $14.4M. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
Not investment advice. Open the BCDA and GPC stock pages for the full models.
Not investment advice.